Loading…
Loading…
REMI does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for REMI and 80,000+ other tickers.
See exactly how REMI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for REMI and 80,000+ other tickers.
Remedent, Inc., operating through its various subsidiaries, specializes in the research, development, manufacturing, and distribution of products for both oral hygiene and aesthetic dentistry. The company's core offerings include professional-grade dental veneers and teeth whitening systems, designed for use by dental practitioners as well as for over-the-counter purchase by consumers. Its innovative product portfolio features River8, a pre-fabricated veneer solution that assists dentists in achieving optimal tooth alignment with minimal patient tooth reshaping. Additionally, Remedent…
Becton, Dickinson and Company (NYSE: BDX - Get Free Report) and Remedent (OTCMKTS:REMI - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk. Analyst Ratings This is a breakdown of
Earnings and Valuation This table compares Escalon Medical and Remedent"s revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Escalon Medical $12.05 million 0.10 $110,000.00 ($0.02) -7.75 Remedent $990,000.00 0.01 -$270,000.00 ($0.01) -0.03 Escalon Medical has higher revenue and earnings than Remedent. Escalon Medical is trading at
Remedent (OTCMKTS:REMI - Get Free Report) and Cooper Companies (NASDAQ: COO - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk. Profitability This table compares Remedent and Cooper Companies' net